Klinik für Innere Medizin III (Kardiologie, Angiologie, Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, 66421 Homburg/Saar, Germany.
Basic Res Cardiol. 2011 Mar;106(2):299-305. doi: 10.1007/s00395-010-0142-z. Epub 2010 Dec 21.
Postnatal vasculogenesis is mediated by endothelial progenitor cells (EPCs) which consist of subpopulations with different functional capacities. Our goal was to profile chemokine receptor expression on relevant subsets of EPCs and to characterize their role for effector functions. CD34(+)/CD133(+)/VEGFR2(+) EPCs were characterized by high expression of chemokine receptors CXCR4, CX3CR1, BLT1, and low level expression of CXCR2 and CCR2, while primordial CD34(-)/CD133(+)/VEGFR2(+) EPCs express these chemokine receptors at comparably low levels. Migration assays revealed that SDF-1, fractalkine, and LTB4 significantly increase migration of CD34(-)/CD133(+)/VEGFR2(+) EPCs, while SDF-1 was the only potent agonist of migration of CD34(+)/CD133(+)/VEGFR2(+) EPCs. SDF-1, fractalkine, and LTB4 trigger significant increase adhesion of CD34(+)/CD133(+)/VEGFR2(+) EPCs, while in CD34(-)/CD133(+)/VEGFR2(+) EPCs SDF-1 and fractalkine are equipotent agonists and LTB4 triggers a smaller though still significant increase in adhesion. Differential expression of specific chemokine receptors is an important regulator in terms of migration and adhesion of biologically relevant EPC-subpopulations, which may have implications for cell therapeutic strategies for treatment of ischemic vascular disease.
产后血管生成是由内皮祖细胞 (EPC) 介导的,其包含具有不同功能能力的亚群。我们的目标是描绘 EPC 相关亚群的趋化因子受体表达,并表征它们在效应功能中的作用。CD34(+)/CD133(+)/VEGFR2(+) EPC 表达高水平的趋化因子受体 CXCR4、CX3CR1、BLT1 和低水平的 CXCR2 和 CCR2,而原始 CD34(-)/CD133(+)/VEGFR2(+) EPC 则以相对较低的水平表达这些趋化因子受体。迁移实验表明,SDF-1、 fractalkine 和 LTB4 显著增加 CD34(-)/CD133(+)/VEGFR2(+) EPC 的迁移,而 SDF-1 是 CD34(+)/CD133(+)/VEGFR2(+) EPC 迁移的唯一有效激动剂。SDF-1、 fractalkine 和 LTB4 显著增加 CD34(+)/CD133(+)/VEGFR2(+) EPC 的黏附,而在 CD34(-)/CD133(+)/VEGFR2(+) EPC 中,SDF-1 和 fractalkine 是等效的激动剂,LTB4 引发的黏附增加虽小但仍具有统计学意义。特定趋化因子受体的差异表达是迁移和黏附生物学相关 EPC 亚群的重要调节因子,这可能对治疗缺血性血管疾病的细胞治疗策略具有重要意义。